News

December 2004 Advertising Opportunities!

A new reference guide clarifies uncertainty surrounding this sometimes misunderstood document.

The first U.S. investigational new drug (IND) clinical trials outside of the United States were conducted in Europe in the late 1970s. In the early 1990s, Central and Eastern Europe (CEE), Latin America, Asia, and selected countries on the African continent (mostly South Africa) became involved in clinical trials.

Interspond’s RxPaging, Scientific Software Tools, Inc.’s VISTA, and Jurilab’s DrugMEt.

October 2004 Supplement Advertising Opportunities

Move away from the "service" model if it means being subservient.

Readers respond to articles and columnists.

Long overlooked as global drug innovators, Japanese pharmaceutical companies are gaining attention for their novel clinical development programs.

Arthur L. Caplan, Ph.D., chair of the University of Pennsylvania's Department of Medical Ethics, expressed his frank views about issues that are ailing the drug industry today during his DIA Keynote Address in mid-June.

Digital dashboards will allow you to pilot your clinical trial from the captain's chair.

Digital dashboards will allow you to pilot your clinical trial from the captain's chair.

Vocel's mDiary, Clinical Systems, Inc.'s ClinBook, and Provisio Inc.'s iTrials

Find out all you need to know about the District of Columbia to impress colleagues and clients.

Welcome to ACT's Washington DC Exhibitor Profiles Supplement for 2004.

A United Nations of taste buds is a mere walk or short cab ride from your hotel. Here are some highlights to whet your appetite.

A map of the area and some welcoming words.

DC day spas for the ultimate in relaxation.

With so many enjoyable and educational opportunities at hand, keeping your spouse and children occupied is an easy task. The dilemma is deciding what to do first!

In contract research and contract bridge, the cards aren't as important as the people holding them.

To better understand the complex world of licensing and enterprise software, consider a driving analogy.

Clinical trials in developing nations-called "ascending markets"-are exploding. These regions offer large naïve subject populations, low operating costs, and increasingly stable testing infrastructures, but regulatory reform is really driving the growth. CenterWatch data show 20%?30% of clinical trials are being conducted in ascending regions.

An extended survey was conducted on the topic of clinical quality assurance (CQA) benchmarking in pharmaceutical companies to gather new data.

Datatrak International's Phase IV, Espicom's World Pharmaceutical Markets, and Keris, Inc.'s Vital Consent

The Uppsala Monitoring Center's WHO Drug Dictionary, Information Mediary's Med-ic Smart Package, and Relsys International Inc.'s Argus J

New requirements for clinical research teams, and administrative responsibilities and constraints for investigators conducting noncommercial trials.

Daniel Callahan (University of California Press, Berkeley, CA, 2003), 341 pages, hardcover, ISBN: 0-520-22771-9. $29.95.

Readers respond to articles and commentaries.

IntraLinks' IntraLinks, Pharsight Corp.'s Trial Simulator, and Thomson CenterWatch's Drugs in Clinical Trials Database and eDirectory of the Clinical Trials Industry